In GC, various diagnostic markers, such as CEA, CA19-9, CA72-4, HLA-G, IL-6, and PD-1 [34,35] have been proposed, and therapeutic targets like HER2, primarily used in advanced stages, have been tested as chemotherapeutic treatments [34,36]. This evidence concerns the gene IL6 and gastric cancer.